Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Arjo AB ( ($SE:ARJO.B) ).
Arjo has scheduled the release of its interim report for the first quarter of 2026 on April 22 at 07:00 CEST, followed by a conference call at 08:00 CEST led by President and CEO Andréas Elgaard and CFO Christofer Carlsson. Fund managers, analysts and media will be able to access the presentation and a long-term recording online, and can register in advance to ask questions verbally, underscoring the company’s ongoing effort to maintain active dialogue and transparency with the capital markets.
The upcoming Q1 disclosure will give investors and stakeholders an early look at Arjo’s performance in the new financial year, which is important given its role supplying critical patient-handling and care solutions to healthcare systems globally. By offering both live participation and long-term replay access, Arjo is aiming to broaden engagement with its financial communications and ensure consistent access to operational and financial updates for a wide range of market participants.
The most recent analyst rating on ($SE:ARJO.B) stock is a Hold with a SEK27.00 price target. To see the full list of analyst forecasts on Arjo AB stock, see the SE:ARJO.B Stock Forecast page.
More about Arjo AB
Arjo is a global healthcare equipment and solutions provider focused on empowering movement in clinical environments to improve quality of care. The company offers products for patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism, serving patients with mobility challenges worldwide.
Average Trading Volume: 643,392
Technical Sentiment Signal: Sell
Current Market Cap: SEK6.9B
For a thorough assessment of ARJO.B stock, go to TipRanks’ Stock Analysis page.